Revance Therapeutics (RVNC) January 5 puts active as share price down 16.5%

September 16, 2024 2:52 PM EDT

Revance Therapeutics (NASDAQ: RVNC) 30-day option implied volatility is at 101; compared to its 52-week range of 14 to 134. Call put ratio 1 call to 2.4 puts with focus on January 5 puts as share price down 16.5%.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Options

Related Entities

Options, Maynard Um, Mark Zuckerberg, ARK